Therapeutic Applications of Anti-depressant Drugs in Fibromyalgia Syndrome

Adam, 1983, ‘Protein synthesis, bodily renewal and the sleep-wake cycle’, Clinical Science, 65, 561, 10.1042/cs0650561 Ahles, 1984, ‘Psychological factors associated with fibromyalgia syndrome’, Arthritis and Rheumatism, 27, 1101, 10.1002/art.1780271004 Bennett, 1988, ‘A comparison of cyclobenzaprine and placebo in the management of fibrositis: A double-blind controlled study’, Arthritis and Rheumatism, 31, 1535, 10.1002/art.1780311210 Bengtsson, 1986, ‘Primary fibromyalgia: A clinical and laboratory study of 55 patients’, Scandinavian Journal of Rheumatology, 15, 340, 10.3109/03009748609092601 Cantini, 1994, ‘Fluoxetine combined with cyclobenzaprine in the treatment of fibromyalgia’, Minerva Medicine, 85, 97 Carette, 1986, ‘Evaluation of amitriptyline in primary fibrositis: A double-blind, placebo-controlled study’, Arthritis and Rheumatism, 29, 655, 10.1002/art.1780290510 Carette, 1994, ‘Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia’, Arthritis and Rheumatism, 37, 32, 10.1002/art.1780370106 Cortet, 1992, ‘Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment: Open study in fibromyalgia’, Revue de Rheumatologie et Maladie Osteo-arthritique, 59, 497 Eschalier, 1994, ‘Why are anti-depressants effective as pain relief?’, CNS Drugs, 2, 261, 10.2165/00023210-199402040-00002 Godfrey, 1996, ‘A guide to the understanding and use of tricyclic anti-depressants in the overall management of fibromyalgia and other chronic pain syndromes’, Archives of Internal Medicine, 156, 1047, 10.1001/archinte.1996.00040041047001 Goldenberg, 1986, ‘A randomised controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia’, Arthritis and Rheumatism, 29, 1371, 10.1002/art.1780291110 Goldenberg, 1996, ‘A randomised, doubleblind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia’, Arthritis and Rheumatism, 39, 1852, 10.1002/art.1780391111 Goodman, 1985, ‘Therapeutic applications and mechanisms of action of monoamine oxidase inhibition and heterocyclic antidepressant drugs’, Journal of Clinical Psychiatry, 46, 6 Kupfer, 1981, ‘Sleep and treatment prediction in endogenous depression’, American Journal of Psychiatry, 138, 429, 10.1176/ajp.138.4.429 Moldofsky, 1975, ‘Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects’, Psychosomatic Medicine, 37, 341, 10.1097/00006842-197507000-00008 Moldofsky, 1976, ‘Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation’, Psychosomatic Medicine, 38, 35, 10.1097/00006842-197601000-00006 Norregard, 1995, ‘A randomised controlled trial of citalopram in the treatment of fibromyalgia’, Pain, 61, 445, 10.1016/0304-3959(94)00218-4 Onhenga, 1992, ‘Anti-depressant-induced analgesia in nonmalignant pain: A metanalysis of 39 placebocontrolled studies’, Pain, 49, 205, 10.1016/0304-3959(92)90144-Z Pilowsky, 1982, ‘A controlled study of amitriptyline in the treatment of chronic pain’, Pain, 14, 169, 10.1016/0304-3959(82)90097-5 Quimby, 1989, ‘A randomised trial of cyclobenzaprine for the treatment of fibromyalgia’, Journal of Rheumatology, 19, 140 Reynolds, 1991, ‘The effects on sleep physiology and symptoms in patients with fibromyalgia’, Journal of Rheumotology, 18, 452 Rush, 1989, ‘Reduced REM latency predicts response to tricyclic medication in depressed out-patients’, Biology of Psychiatry, 26, 61, 10.1016/0006-3223(89)90008-5 Scudds, 1989, ‘Improvements in pain responsiveness in patients with fibromyalgia’, Journal of Rheumatology, 16, 98 Tollison, 1988, ‘Selected tricyclic anti-depressants in the management of chronic benign pain’, Southern Medical Journal, 81, 562, 10.1097/00007611-198805000-00004 Yunus, 1993, ‘Research in fibromyalgia and myofasial pain syndromes: Current status, problems and future directions’, Journal of Musculoskeletal Pain, 1, 23, 10.1300/J094v01n01_05 Wolfe, 1990, ‘The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee’, Arthritis and Rheumatism, 33, 160, 10.1002/art.1780330203 Wolfe, 1994, ‘A double-blind controlled trial of fluoxetine in fibromyalgia’, Scandinavian Journal of Rheumatology, 23, 255, 10.3109/03009749409103725 Wysenbeek, 1985, ‘Imipramine for the treatment of fibrositis: A therapeutical trial’, Annals of the Rheumatic Diseases, 44, 752, 10.1136/ard.44.11.752